Ken Griffin Artivion, Inc. Put Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$24.33 - $28.46 $143,547 - $167,914	-5,900 Reduced 86.76%	900 $23,000
Q2 2024 Aug 14, 2024	BUY	$19.62 - $25.65 $103,986 - $135,945	5,300 Added 353.33%	6,800 $174,000
Q1 2024 May 15, 2024	SELL	$16.7 - $21.63 $73,480 - $95,172	-4,400 Reduced 74.58%	1,500 $31,000
Q4 2023 Feb 14, 2024	BUY	$12.33 - $18.83 $70,281 - $107,330	5,700 Added 2850.0%	5,900 $105,000
Q3 2023 Nov 14, 2023	SELL	$14.82 - $17.52 $4,446 - $5,256	-300 Reduced 60.0%	200 $3,000
Q2 2023 Aug 14, 2023	SELL	$12.78 - $17.23 $12,780 - $17,230	-1,000 Reduced 66.67%	500 $8,000
Q1 2023 May 15, 2023	BUY	$11.74 - $14.12 $11,740 - $14,120	1,000 Added 200.0%	1,500 $19,000
Q4 2022 Feb 14, 2023	BUY	$10.01 - $13.9 $5,005 - $6,950	500 New	500 $6,000

174

35.8M

33K

900

Ticker AORT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,316,100
Market Cap $1.15B
Description
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.